1.36
price down icon5.56%   -0.08
after-market Handel nachbörslich: 1.28 -0.08 -5.88%
loading
Schlusskurs vom Vortag:
$1.44
Offen:
$1.43
24-Stunden-Volumen:
348.22K
Relative Volume:
0.39
Marktkapitalisierung:
$132.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.73M
KGV:
-10.46
EPS:
-0.13
Netto-Cashflow:
$-3.92M
1W Leistung:
+27.10%
1M Leistung:
+10.57%
6M Leistung:
+37.33%
1J Leistung:
+61.69%
1-Tages-Spanne:
Value
$1.29
$1.43
1-Wochen-Bereich:
Value
$1.01
$1.53
52-Wochen-Spanne:
Value
$0.5437
$1.91

Tiziana Life Sciences Ltd Stock (TLSA) Company Profile

Name
Firmenname
Tiziana Life Sciences Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
9
Name
Twitter
@tizianals
Name
Nächster Verdiensttermin
2024-05-27
Name
Neueste SEC-Einreichungen
Name
TLSA's Discussions on Twitter

Vergleichen Sie TLSA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TLSA
Tiziana Life Sciences Ltd
1.36 132.04M 0 -13.73M -3.92M -0.13
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-12-22 Eingeleitet B. Riley Securities Buy
2018-12-17 Eingeleitet Laidlaw Buy

Tiziana Life Sciences Ltd Aktie (TLSA) Neueste Nachrichten

pulisher
Apr 24, 2025

Dosing begins in Tiziana Life Sciences’ trial of foralumab for na-SPMS - Yahoo Finance

Apr 24, 2025
pulisher
Apr 24, 2025

How to interpret Tiziana Life Sciences Ltd (TLSA)’s stock chart patterns - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Tiziana Life Sciences Ltd: A Comprehensive Look at the Stock’s Ups and Downs - investchronicle.com

Apr 24, 2025
pulisher
Apr 23, 2025

Small cap wrap: Tiziana Life Sciences, Excellon Resources, Lancaster Resources... - Proactive Investors

Apr 23, 2025
pulisher
Apr 23, 2025

Tiziana Life Sciences Announces University of Massachusetts Starts Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Breakthrough MS Treatment Trial: UMass Joins Harvard, Yale, Johns Hopkins Testing Home-Use Nasal Drug - Stock Titan

Apr 23, 2025
pulisher
Apr 23, 2025

Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2… - Informazione.it

Apr 23, 2025
pulisher
Apr 23, 2025

Tiziana Life Sciences announces patient dosing in Phase 2 MS trial - Proactive financial news

Apr 23, 2025
pulisher
Apr 08, 2025

Multiple sclerosis Pipeline Analysis and Clinical Trials - openPR.com

Apr 08, 2025
pulisher
Apr 02, 2025

TLSATiziana Life Sciences Ltd Com Latest Stock News & Market Updates - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

Small cap wrap: Zero Candida, Midnight Sun Mining, Tiziana Life Sciences, Trust Stamp... - Proactive financial news

Apr 02, 2025
pulisher
Apr 02, 2025

Tiziana Life Sciences begins patient dosing in Phase 2 MS trial at Johns Hopkins - Proactive financial news

Apr 02, 2025
pulisher
Apr 02, 2025

Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab In Phase 2 Multiple Sclerosis Clinical Trial - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Major Breakthrough: Johns Hopkins Launches Novel Nasal Treatment in Phase 2 MS Trial - Stock Titan

Apr 02, 2025
pulisher
Mar 26, 2025

Tiziana Life Sciences begins dosing in trial of therapy for multiple sclerosis - Yahoo Finance

Mar 26, 2025
pulisher
Mar 26, 2025

Tiziana Life Sciences begins dosing in Phase 2 trial for intranasal foralumab in SPMS - Proactive financial news

Mar 26, 2025
pulisher
Mar 25, 2025

Small cap wrap: Northern Superior Resources, Tiziana Life Sciences, Alternus Clean Energy... - Proactive Investors

Mar 25, 2025
pulisher
Mar 25, 2025

Multiple sclerosis Clinical Trials and Studies 2025: EMA, PDMA, - openPR

Mar 25, 2025
pulisher
Mar 25, 2025

Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Yale Launches Groundbreaking Intranasal MS Treatment Trial: Tiziana's Innovation in Focus - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Tiziana Life Sciences Ltd Files For Mixed Shelf Of Up To $250 MillionSEC Filing -March 24, 2025 at 05:22 pm EDT - Marketscreener.com

Mar 24, 2025
pulisher
Mar 17, 2025

Tiziana Life Sciences CEO to present at 37th Annual ROTH Conference - Proactive Investors UK

Mar 17, 2025
pulisher
Mar 17, 2025

Tiziana Life Sciences to Present at the 37th Annual Roth Conference - The Manila Times

Mar 17, 2025
pulisher
Mar 17, 2025

Tiziana Life Sciences Reveals Growth Strategy at Major ROTH ConferenceKey Updates Expected - StockTitan

Mar 17, 2025
pulisher
Mar 14, 2025

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule - The Manila Times

Mar 14, 2025
pulisher
Mar 14, 2025

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Requirements - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Tiziana Life Sciences Regains Compliance With Nasdaq Listing Minimum Bid Price Rule - MENAFN.COM

Mar 14, 2025
pulisher
Mar 14, 2025

Tiziana Life Sciences Dodges Delisting: How Company Saved Its Nasdaq Status - Stock Titan

Mar 14, 2025
pulisher
Mar 13, 2025

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential - Simply Wall St

Mar 13, 2025
pulisher
Mar 10, 2025

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease - Informazione.it

Mar 10, 2025
pulisher
Mar 10, 2025

Can Tiziana's Foralumab Enable Breakthroughs In Neuroinflammatory And Neurodegenerative Diseases? - RTTNews

Mar 10, 2025
pulisher
Mar 07, 2025

Tiziana Life Sciences stock soars to 52-week high of $1.75 - Investing.com

Mar 07, 2025
pulisher
Mar 06, 2025

Democrat-led states join legal fight over Trump's mass firings of federal workers -March 06, 2025 at 10:38 pm EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Tiziana Life Sciences Ltd. (NASDAQ: TLSA) Stock Hits Multi-Month High After Filing a Key IND with the FDA - DRP Journal

Mar 06, 2025
pulisher
Mar 05, 2025

Tiziana: Foralumab Drug Development Presses On With Additional EAP Enrollment - Seeking Alpha

Mar 05, 2025
pulisher
Mar 04, 2025

Sector Update: Health Care -March 04, 2025 at 03:39 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Tiziana submits FDA investigational new drug application - Proactive Investors UK

Mar 04, 2025
pulisher
Mar 04, 2025

Tiziana Life Sciences Files New Drug Application for ALS Drug Candidate -March 04, 2025 at 09:03 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Tiziana Life Sciences Advances ALS Treatment with FDA IND Submission - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Tiziana Life Sciences Files Investigational New Drug Application With FDA For ALS Phase 2 Clinical Trial - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Could This Intranasal Therapy Change ALS Treatment? Tiziana Seeks FDA Approval - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Tiziana Life Sciences Ltd (NASDAQ:TLSA) Sees Significant Drop in Short Interest - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN

Mar 03, 2025
pulisher
Mar 02, 2025

Why Tiziana Life Sciences Ltd (TLSA) is Skyrocketing So Far in 2025 - Insider Monkey

Mar 02, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 27, 2025

Tiziana stock jumps 12% on TBI drug study publication - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Tiziana Life Sciences' lead candidate demonstrates favorable safety profile and clinical response - Proactive Investors UK

Feb 27, 2025
pulisher
Feb 27, 2025

Market movers: Ideal Power, Tiziana Life Sciences, Medicus Pharma... - Proactive financial news

Feb 27, 2025

Finanzdaten der Tiziana Life Sciences Ltd-Aktie (TLSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):